United States - English - NLM (National Library of Medicine)

masteam bio-tech co., ltd. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - tulathromycin 1 kg in 1 kg

United States - English - NLM (National Library of Medicine)

attix pharmaceuticals - tulathromycin a (unii: 897a3kn7ap) (tulathromycin - unii:q839i13422) - tulathromycin a 1 kg in 1 kg

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - tulathromycin a (unii: 897a3kn7ap) (tulathromycin a - unii:897a3kn7ap) - tulathromycin a 495 g in 500 g

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - tulathromycin a (unii: 897a3kn7ap) (tulathromycin a - unii:897a3kn7ap) - tulathromycin a 485 g in 500 g

United States - English - NLM (National Library of Medicine)

zoetis inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - tulathromycin 25 mg in 1 ml - swine draxxin 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae , pasteurella multocida , bordetella bronchiseptica , haemophilus parasuis , and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae , pasteurella multocida , and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd - draxxin 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . the use of draxxin 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug.

United States - English - NLM (National Library of Medicine)

zoetis inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - tulathromycin 100 mg in 1 ml - brd  – draxxin injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . ibk  – draxxin injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot  – draxxin injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum  and porphyromonas levii . brd  – draxxin injectable solution is indicated for the treatment of brd associated with m. haemolytica, p. multocida, h. somni,  and m. bovis. draxxin injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoni

United States - English - NLM (National Library of Medicine)

american pharmaceutical ingredients llc - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) -

United States - English - NLM (National Library of Medicine)

zoetis inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422), ketoprofen (unii: 90y4qc304k) (ketoprofen - unii:90y4qc304k) - draxxin® kp is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis , and control of pyrexia associated with brd in beef steers, beef heifers, beef calves 2 months of age and older, beef bulls, dairy bulls, and replacement dairy heifers. not for use in reproducing animals over one year of age, dairy calves, or veal calves. the use of draxxin kp injection is contraindicated in animals previously found to be hypersensitive to tulathromycin and ketoprofen. not for human use. keep out of reach of children. the safety data sheet (sds) provides more detailed occupational safety information. to obtain a safety data sheet contact zoetis inc. at 1-888-963-8471.

United States - English - NLM (National Library of Medicine)

elanco us inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - swine increxxa 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica, haemophilus parasuis, and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae, pasteurella multocida, and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd - increxxa 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis . the use of increxxa 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug.

United States - English - NLM (National Library of Medicine)

virbac ah, inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - swine tulissin 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica, haemophilus parasuis, and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae, pasteurella multocida, and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd - tulissin 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis. the use of tulissin 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug. residue warnings swine swine intended for human consumption must not be slaughtered within 5 days from the last treatment. calves calves intended for human consumption must not be slaughtered within 22